Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

No-Receipt date 2014-02250 - 29/07/2014
No-Filing date 20140401513 - 29/07/2014
No-Granting date 3083970 - 31/07/2014
No-EPO application date 10748211.9 - 27/08/2010
No-EPO granting date 2470526 - 28/05/2014
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 7/2014 - 01/09/2014
Expiration date 28/08/2030
Kind of title Validation of European Patent
Legal status VALID
Priorities US238073 P28/08/2009/US
US313039 P11/03/2010/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07D 403/04
C07D 401/14
A61P 35/00
A61K 31/506

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20190800011

Owners
CodeFirstnameSurnameAddressTownZIPCountry
755000 ARRAY BIOPHARMA INC. 3200 WALNUT STREETBOULDER, COLORADO 80301, U.S.A. UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1314647 HUANG, SHENLIN
1314648 JIN, XIANMING
1314649 LIU, ZUOSHENG
1314650 POON, DANIEL
1314651 TELLEW, JOHN
1314652 WAN, YONGQIN
1314653 WANG, XING
1314654 XIE, YONGPING

Representatives
CodeFirstnameSurnameAddressTownZip
1349ELENIPAPAKONSTANTINOUKOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History
Date Description Comments Data before modification Data after modification
19/03/2019 Συγχωνεύσεις Εταιριών (7e803) Α.Π.2684-Η.Θ.69342/15-3-19,ΔΝΥ.831/11-6-18, ΚΩΔ.ΠΛΗΡ.3458 546118 IRM LLC 131 Front Street P.O. Box HM 2899 ΒΕΡΜΟΥΔΕΣ Hamilton HM LX
19/03/2019 Συγχωνεύσεις Εταιριών (7e803) Α.Π.2684-Η.Θ.69342/15-3-19,ΔΝΥ.831/11-6-18, ΚΩΔ.ΠΛΗΡ.3458 683843 Novartis International Pharmaceutical Ltd. 131 Front Street ΒΕΡΜΟΥΔΕΣ Hamilton HM LX, BERMUDA
19/03/2019 Μεταβίβαση (7e802) Α.Π.2683-Η.Θ.69340/15-3-19, ΔΝΥ.831/11-6-18, ΚΩΔ.ΠΛΗΡ.3458 546119 Novartis AG Lichtstrasse 35 ΕΛΒΕΤΙΑ 4056 Basel, SWITZERLAND
19/03/2019 Μεταβίβαση (7e802) Α.Π.2683-Η.Θ.69340/15-3-19, ΔΝΥ.831/11-6-18, ΚΩΔ.ΠΛΗΡ.3458
19/03/2019 Μεταβίβαση (7e802) Α.Π.2685-Η.Θ.69355/15-3-19, ΔΝΥ.831/11-6-18, ΚΩΔ.ΠΛΗΡ.3458
01/06/2021 Συγχωνεύσεις Εταιριών (7e803) Α.Π.6441, ΑΡ.ΥΠ.4283220/21, ΔΝΥ.910, ΚΩΔ.ΠΛΗΡ.3458., Η εταιρεία: "Arlington Acquisition Sub Inc." συγχωνεύτηκε με την εταιρεία: ARRAY BIO......, που αποτελεί την συνΔΙΚΑΙΟΥΧΟ.

Title Instruments
DateOperationDescreption
5/9/2022 12:00:00 AMΔιάφορες Μεταβολές (70004) Η Δικαιούχος ARRAY....δήλωσε οτι παραχώρησε αποκλειστική άδεια εκμετάλλευσης στην εταιρεία: "Pierre Fabre Medicament" με έδρα 92100 Boulogne-Billancourt, FRANCE
10/17/2023 12:00:00 AMΔιάφορες Μεταβολές (70004) ΑΡ.ΠΡΩΤ. 4430/10-02-2023 (ΛΙΣΤΑ) (ΑΡ.ΥΠΟΘ. 4654017/10-02-2023) ΔΝΥ. 440 ΑΡΣΗ & ΑΝΤΙΚΑΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ

Payments history 15 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015